From the Journals News

Does Tissue TMB Outperform Blood-Based Testing for Predicting Immunotherapy Response

June 4, 2026
Share Share via Email Share on Facebook Share on LinkedIn Share on X
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.